Cormorant Asset Management, LP - Sep 30, 2025 SCHEDULE 13G/A Report for VYNE Therapeutics Inc. Common Stock, par value $0.0001 per share (VYNE)

Filing Manager: Cormorant Asset Management, LP
Reporting Manager: Cormorant Asset Management, LP
Security: VYNE Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol: VYNE
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 01:10 PM
Date of event: Sep 30, 2025
Previous filing: Aug 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Cormorant Asset Management, LP	0%	0	0	0	/s/ Bihua Chen	Bihua Chen, Managing Member
Bihua Chen	0%	0	0	0	/s/ Bihua Chen	Bihua Chen